Dietary Supplement Regulation – A Brief Overview

Dietary supplement regulation could be describedto guide individual businesses falling into this grey
as something of a bit of a grey area. In the US,area.
dietary supplement regulation falls separatelyIt's essential therefore that businesses and
under a piece of legislation known as the Dietarymanufacturers of dietary supplements make sure
Supplement Health and Education Act of 1994that they take advice about supplement regulation
(DSHEA) which is regulated by the food andand the category in which their product fits or
Drugs Agency (FDA). Similarly in the UK, dietarywhether it is requires further and more detailed
supplement regulation is recognised as being aregulation. Claims made about Vitamin C tablets
unique area of manufacture and marketing, if notbeing the cure for the ‘common cold' for
always clear-cut and distinct. In the UK thereforeexample would render the product a medicine and
dietary supplement regulation covers productsit would then be subject to stringent tests before
that are described as ‘borderline' products.being released as a ‘common cold' cure. Of
Borderline products and the items covered by thecourse, it is not a cure for the common cold, and
US supplement regulation seek to clarify a greywhilst it is well documented that a lack of certain
area between medicines and foods in which manyvitamins like but not exclusively Vitamin C can
products don't immediately belong anywhere else.contribute to a person acquiring certain
As an example, toothpaste that doesn't make‘common cold' type symptoms – which is
medicinal claims about its product, but wants tovery different from saying that it's the cure for
market it by telling people that it can ‘cure'that set of symptoms.
sensitive teeth. If it were to advertise the latter,Supplement regulation therefore is a tricky
then the toothpaste would fall into the medicalbalancing act between allowing manufacturers to
category requiring it to be subject to medicalproduce and sell products that may carry some
regulation, rather than that of cosmetics. This inhealth benefit to consumers, but which cannot
turn has a cost to the company manufacturingovertly be sold with this as its objective.
the product. The MHRA Borderline Team is there